1. Home
  2. ADCT vs TCI Comparison

ADCT vs TCI Comparison

Compare ADCT & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • TCI
  • Stock Information
  • Founded
  • ADCT 2011
  • TCI 1983
  • Country
  • ADCT Switzerland
  • TCI United States
  • Employees
  • ADCT N/A
  • TCI N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • ADCT Health Care
  • TCI Finance
  • Exchange
  • ADCT Nasdaq
  • TCI Nasdaq
  • Market Cap
  • ADCT 285.2M
  • TCI 240.5M
  • IPO Year
  • ADCT 2020
  • TCI N/A
  • Fundamental
  • Price
  • ADCT $1.98
  • TCI $28.00
  • Analyst Decision
  • ADCT Strong Buy
  • TCI
  • Analyst Count
  • ADCT 5
  • TCI 0
  • Target Price
  • ADCT $7.33
  • TCI N/A
  • AVG Volume (30 Days)
  • ADCT 417.8K
  • TCI 2.2K
  • Earning Date
  • ADCT 11-07-2024
  • TCI 11-07-2024
  • Dividend Yield
  • ADCT N/A
  • TCI N/A
  • EPS Growth
  • ADCT N/A
  • TCI N/A
  • EPS
  • ADCT N/A
  • TCI 0.37
  • Revenue
  • ADCT $70,717,000.00
  • TCI $49,821,000.00
  • Revenue This Year
  • ADCT $6.66
  • TCI N/A
  • Revenue Next Year
  • ADCT $16.38
  • TCI N/A
  • P/E Ratio
  • ADCT N/A
  • TCI $75.25
  • Revenue Growth
  • ADCT N/A
  • TCI 4.46
  • 52 Week Low
  • ADCT $0.69
  • TCI $26.29
  • 52 Week High
  • ADCT $6.04
  • TCI $43.40
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 25.90
  • TCI 51.94
  • Support Level
  • ADCT $1.89
  • TCI $27.80
  • Resistance Level
  • ADCT $3.06
  • TCI $28.00
  • Average True Range (ATR)
  • ADCT 0.23
  • TCI 0.44
  • MACD
  • ADCT -0.11
  • TCI 0.05
  • Stochastic Oscillator
  • ADCT 8.83
  • TCI 78.80

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: